Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|February 27, 2016
Implications of Programmed Cell Death 1 Ligand 1 Heterogeneity in the Selection of Patients With Non-Small Cell Lung Cancer to Receive ImmunotherapyA S Mansfield, H Dong
Thrombosis Research|October 24, 2015
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trialsA S Mansfield, A J Tafur, D Vulih, et al.
Clinical and Experimental Immunology|October 9, 2012
Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexesA S Mansfield, W K Nevala, R S Dronca, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2016
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancerA S Mansfield, A J Tafur, C E Wang, et al.
Thrombosis Research|April 14, 2017
Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancerH E Fuentes, D M Oramas, L H Paz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancerA S Mansfield, M C Aubry, J C Moser, et al.
Thrombosis Research|October 18, 2015
Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosisA J Tafur, G Dale, M Cherry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Annals of Surgical Oncology|March 26, 2014
A predictive tool to estimate the risk of axillary metastases in breast cancer patients with negative axillary ultrasoundT J Meretoja, P S Heikkilä, A S Mansfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trialA S Mansfield, A Każarnowicz, N Karaseva, et al.
Pageof 2